Livzon Pharmaceutical Group Inc. (FRA:LP6)
Germany flag Germany · Delayed Price · Currency is EUR
3.040
-0.040 (-1.30%)
At close: Jan 30, 2026

FRA:LP6 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Jan '22 Jan '21
Cash & Equivalents
9,91910,82711,32610,4119,1469,954
Trading Asset Securities
1,12689.3681.79108.09182.7725.98
Cash & Short-Term Investments
11,04510,91711,40810,5199,3299,980
Cash Growth
2.18%-4.30%8.44%12.76%-6.52%12.48%
Accounts Receivable
3,2783,2493,5754,0393,2942,892
Other Receivables
52.9859.2851.9131.3264.3792.85
Receivables
3,3313,3083,6274,0713,3582,985
Inventory
1,6571,9982,0612,0451,6631,488
Other Current Assets
540.01197.44171.11352322.42174.88
Total Current Assets
16,57216,42017,26616,98714,67314,627
Property, Plant & Equipment
4,3584,5374,5664,5924,2393,707
Long-Term Investments
1,6451,6181,6701,7381,695988.09
Goodwill
124.91124.91124.91103.04103.04103.04
Other Intangible Assets
478.72403.68426.28557.44260.28236.43
Long-Term Deferred Tax Assets
416.2356.35301.92283.89252.69238.23
Long-Term Deferred Charges
516.92396.25468.62416.74704.41373.49
Other Long-Term Assets
425.62599.54221.17189.66444.62317.09
Total Assets
24,53824,45625,04524,86822,37220,591
Accounts Payable
1,3041,5841,6581,8621,8171,625
Accrued Expenses
301.133,1093,2953,2492,6562,467
Short-Term Debt
2,4402,4551,8601,6222,0431,551
Current Portion of Long-Term Debt
106.3136.21647.47---
Current Portion of Leases
-12.5312.210.449.288.54
Current Income Taxes Payable
261.23112.88181.5892.5797.45179.51
Current Unearned Revenue
69.22124.63138226.19167.8104.45
Other Current Liabilities
2,877191.27294.49334.42134.34147.17
Total Current Liabilities
7,3587,6258,0877,3976,9256,083
Long-Term Debt
1,3571,4661,6131,974636.78360.32
Long-Term Leases
13.9813.19.0311.615.2710.1
Long-Term Unearned Revenue
231.18238.42269.37273.21258.88276.14
Long-Term Deferred Tax Liabilities
210.49207.39209.81191.96156.89143.28
Other Long-Term Liabilities
--90847878
Total Liabilities
9,1719,55010,2789,9328,0616,951
Common Stock
904.1911.35923.94935.55937.87944.84
Additional Paid-In Capital
298.83529.241,3221,4221,6291,457
Retained Earnings
13,27112,50611,65311,18210,4619,682
Treasury Stock
-570.31-196.62--55.94-71.21-250.06
Comprehensive Income & Other
59.15112.18143.07391.6446.55273.78
Total Common Equity
13,96313,86214,04213,87613,00412,107
Minority Interest
1,4041,043724.211,0601,3071,533
Shareholders' Equity
15,36714,90614,76714,93614,31113,640
Total Liabilities & Equity
24,53824,45625,04524,86822,37220,591
Total Debt
3,9173,9834,1413,6192,6941,930
Net Cash (Debt)
7,1276,9347,2666,9016,6358,050
Net Cash Growth
6.25%-4.57%5.29%4.01%-17.58%7.16%
Net Cash Per Share
7.937.537.817.377.098.58
Filing Date Shares Outstanding
888.72908.91923.94932.23929.97932.47
Total Common Shares Outstanding
888.72908.91923.94932.23929.97944.84
Working Capital
9,2148,7959,1799,5917,7488,544
Book Value Per Share
15.7115.2515.2014.8813.9812.81
Tangible Book Value
13,35913,33413,49113,21612,64011,768
Tangible Book Value Per Share
15.0314.6714.6014.1813.5912.45
Buildings
-3,9123,745-3,1232,970
Machinery
-4,8174,5517,5773,7643,216
Construction In Progress
-257.37289.31602.44554.58385.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.